Literature DB >> 10873632

Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells.

H Bamba1, S Ota, A Kato, C Kawamoto, K Fujiwara.   

Abstract

We previously reported that cyclooxygenase (COX)-2 was predominantly expressed in macrophages of human colonic adenomas (Int. J. Cancer 83, 470-475.). The role of prostaglandins (PGs) produced by COX-2-expressing macrophages in colon carcinogenesis is still unclear. Here we show that PGs up-regulate vascular endothelial growth factor (VEGF) production by activated macrophages through their specific receptors. mRNAs of both PGE-specific receptors and peroxisome proliferator-activated receptor gamma (PPARgamma), a member of the nuclear receptor superfamily of ligand-dependent transcription factors, were expressed in phorbol 12-myristate 13-acetate-differentiated U937, a human macrophage model (H-Mac). Prostaglandin E(1) (PGE(1)) and 15-deoxy-Delta(12,14)-PGJ(2) (a potent PPARgamma ligand, 15d-PGJ(2)) dramatically increased VEGF production. The combination of PGE(1) and 15d-PGJ(2) additively increased VEGF production. In addition, PGE(1) significantly increased cAMP formation, whereas 15d-PGJ(2) did not affect cAMP formation. The effect of the combination of PGE(1) and 15d-PGJ(2) on cAMP formation was similar to that of PGE(1) alone. Unexpectedly, 15d-PGJ(2) also drastically increased IL-1beta production, an indicator of macrophage activation, although PGE(1) only mildly increased it. Additional enhancement of IL-1beta production was observed in the combination of PGE(1) and 15d-PGJ(2). These results suggest that PGs dramatically increased VEGF production by activated macrophages through specific PGE receptor and PPARgamma-mediated processes and that PGs may thereby promote tumor growth through VEGF production. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873632     DOI: 10.1006/bbrc.2000.2969

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Adenocarcinoma within a diverticulum: a common tumor arising in an uncommon location.

Authors:  Charles F Bellows; Salima Haque
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

Review 2.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  Effects of 15d-PGJ(2) on VEGF-induced angiogenic activities and expression of VEGF receptors in endothelial cells.

Authors:  Philip Funovics; Christine Brostjan; Anneliese Nigisch; Anna Fila; Anna Grochot; Katarzyna Mleczko; Halina Was; Guenter Weigel; Jozef Dulak; Alicja Jozkowicz
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-03-31       Impact factor: 3.072

Review 4.  Role of cyclooxygenase-2 in gastric cancer development and progression.

Authors:  Jian Cheng; Xiao-Ming Fan
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

5.  Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.

Authors:  Kevin Wood; Elizabeth Byron; Linda Janisch; Ravi Salgia; Manish R Sharma
Journal:  Am J Clin Oncol       Date:  2018-10       Impact factor: 2.339

6.  15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?

Authors:  William S Powell
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  Association between COX-2 expression and effectiveness of COX-2 inhibitors in a phase II trial in patients with metastatic colorectal adenocarcinoma.

Authors:  Khaldoun Almhanna; Bassel El-Rayes; Seema Sethi; Gregory Dyson; Lance Heilbrun; Philip A Philip; Fazlul Sarkar
Journal:  Anticancer Res       Date:  2012-08       Impact factor: 2.480

8.  Novel mechanisms and signaling pathways of esophageal ulcer healing: the role of prostaglandin EP2 receptors, cAMP, and pCREB.

Authors:  Amrita Ahluwalia; Dolgor Baatar; Michael K Jones; Andrzej S Tarnawski
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-24       Impact factor: 4.052

9.  Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.

Authors:  Bassel F El-Rayes; Mark M Zalupski; Stephanie G Manza; Barbara Rusin; Ann Marie Ferris; Ulka Vaishampayan; Lance K Heilbrun; Raghu Venkatramanamoorthy; Anthony F Shields; Philip A Philip
Journal:  Cancer Chemother Pharmacol       Date:  2007-04-12       Impact factor: 3.333

10.  Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis.

Authors:  Shah Jahan; Saba Khaliq; Bushra Ijaz; Waqar Ahmad; Sajida Hassan
Journal:  Virol J       Date:  2011-04-01       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.